Frontiers in Oncology (Sep 2024)
Case report: Cardiac neuroendocrine carcinoma and squamous cell carcinoma treated with MR-guided adaptive stereotactic radiation therapy
- Xinru Chen,
- Xinru Chen,
- Julius K. Weng,
- Angela Sobremonte,
- Belinda M. Lee,
- Neil W. Hughes,
- Mustefa Mohammedsaid,
- Yao Zhao,
- Xiaochun Wang,
- Xiaochun Wang,
- Xiaodong Zhang,
- Xiaodong Zhang,
- Joshua S. Niedzielski,
- Joshua S. Niedzielski,
- Sanjay S. Shete,
- Sanjay S. Shete,
- Laurence E. Court,
- Laurence E. Court,
- Zhongxing Liao,
- Percy P. Lee,
- Jinzhong Yang,
- Jinzhong Yang
Affiliations
- Xinru Chen
- Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Xinru Chen
- The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, United States
- Julius K. Weng
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Angela Sobremonte
- Department of Radiation Therapeutic Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Belinda M. Lee
- Department of Radiation Therapeutic Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Neil W. Hughes
- Department of Radiation Therapeutic Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Mustefa Mohammedsaid
- Department of Radiation Therapeutic Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Yao Zhao
- Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Xiaochun Wang
- Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Xiaochun Wang
- The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, United States
- Xiaodong Zhang
- Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Xiaodong Zhang
- The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, United States
- Joshua S. Niedzielski
- Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Joshua S. Niedzielski
- The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, United States
- Sanjay S. Shete
- The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, United States
- Sanjay S. Shete
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Laurence E. Court
- Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Laurence E. Court
- The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, United States
- Zhongxing Liao
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Percy P. Lee
- Department of Radiation Oncology, City of Hope Orange County, Lennar Foundation Cancer Center, Irvine, CA, United States
- Jinzhong Yang
- Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Jinzhong Yang
- The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, United States
- DOI
- https://doi.org/10.3389/fonc.2024.1411474
- Journal volume & issue
-
Vol. 14
Abstract
We present two cases of cardiac metastases adjacent to the right ventricle in a 55-year-old male and a 61-year-old female, both treated with magnetic resonance (MR)-guided adaptive stereotactic radiation therapy (SBRT). The prescribed regimen was 30Gy delivered in 3 fractions using a 1.5 Tesla magnetic resonance linear accelerator (MR-linac). Patients exhibited favorable tolerance to the treatment, with no observed acute toxicity.
Keywords
